Humanoid Robot Startup Valuation Bubble: Boom Signal or Breaking Point?
South Korea’s Tomorrow Robotics entered 2025 worth roughly 30 billion won. Less than a year later, it is targeting a valuation of 450 billion won — approximately $323 million — a jump of more than 15x without a single publicly confirmed commercial deployment. That single data point is the sharpest lens through which to read the humanoid robot startup valuation bubble forming right now across Seoul, San Francisco, and Shanghai.
So are humanoid robot startups overvalued in 2026? The honest answer is: some clearly are, some may not be, and the problem is that most current analysis does not separate those two groups. This article tries to fix that — with real numbers, cross-market context, and the questions every VC analyst and retail investor should be asking before the next megaround press release lands in their inbox.
How Fast Are These Valuations Actually Moving?
The velocity is genuinely unusual. Tomorrow Robotics is not an outlier inside South Korea. Fellow Seoul startup Diden Robotics is conducting a Series A at a target valuation of 500 billion won ($359 million), while Holiday Robotics recently closed a 155 billion won round at a 750 billion won ($538 million) valuation — the largest Series A financing in Korean startup history. Local VC executives are blunt about what this means. One fund chief quoted in the original Korean reporting noted that it is “highly unusual for startups to be valued in the hundreds of billions of won at such an early stage,” adding that the critical question is whether backers will exit in five to six years above current levels.
That exit anxiety is entirely rational. Korea’s humanoid robotics VC exit risk is structural: the domestic public market has thin appetite for pure-play robotics listings, and the global IPO window for embodied AI companies remains essentially shut for pre-revenue names.
Zoom out and the US picture looks just as stretched. Figure AI hit a $39 billion post-money valuation in September 2025 after exceeding $1 billion in Series C commitments, a 15x markup from its $2.6 billion Series B valuation just 19 months earlier. The company’s revenue has never been publicly disclosed. Third-party estimates place 2025 shipments around 150 robots — and at a Robot-as-a-Service price of approximately $1,000 per robot per month, that implies implied annual revenue in the low tens of millions at best. The Figure AI valuation vs revenue gap, in other words, may sit at four-digit multiples. Goldman Sachs projects the entire global humanoid robot market at $38 billion by 2035. Figure’s last confirmed valuation already exceeds that nine years in advance.
The Physical AI Funding Surge: Where the Money Is Going
The broader humanoid startup funding surge today is staggering in scale. Roughly $56 billion has flowed into robotics companies in 2026 — nearly double the previous year’s total, with the overwhelming share landing in the US and China. Series A megaround sizes that would have been headline news in 2022 are now table stakes. The median disclosed round in the humanoid robotics sector between August 2025 and June 2026 was $145 million. Rounds above $50 million now represent 84% of all disclosed deals by capital.
The money is chasing a real thesis. Labor shortage automation is a genuine macro driver — persistent workforce gaps in logistics, manufacturing, and eldercare create a credible total addressable market. Embodied AI, the convergence of large vision-language-action models with physical bipedal robot hardware, genuinely did not exist as a commercial concept five years ago. The physical AI category has real technical progress behind it, not just slides.
What it does not yet have, at most companies, is revenue that justifies the price tag.
The Dotcom Bubble Parallel: Useful But Imprecise
The humanoid robot IPO bubble latest comparison every analyst reaches for is the dotcom era, and it is partially correct. From a pure valuation perspective, there are meaningful parallels between current market conditions and the dotcom bubble — eye-watering prices, absent profits, and narratives priced on decade-long market capture. The flood of AI capital is pushing humanoid robotics toward a speculative zone, with too many startups promising breakthroughs without commercial evidence.
But the parallel has limits. The dotcom peak was built on companies with no revenue and debt-heavy balance sheets. The biggest players in today’s physical AI startup overvaluation update — Figure, Skild AI, Apptronik — are backed by strategics like Nvidia, Brookfield, and NVIDIA with actual deployment infrastructure being built. Figure’s robots logged over 1,250 runtime hours at BMW’s Spartanburg factory before the Series C closed. That is a lighthouse customer, not a demo reel.
The more precise comparison may be the 2013–2014 3D printing hype cycle. Real technology. Genuine industrial use cases. Premature consumer timelines. And a correction that wiped out a generation of pure-play public names while the underlying tech quietly went on to penetrate manufacturing at scale.
China’s own economic planners flagged the tension directly: the country’s National Development and Reform Commission noted that the humanoid robotics industry needs to balance growth speed against the risks of bubbles, with more than 150 companies now competing in the sector.
Comparing Exit Risk Across the US, Korea, and China
This is the gap most coverage ignores entirely. The humanoid robot VC hype cycle compared to dotcom looks different depending on which country’s market you are actually trying to exit from.
| Market | Key Dynamic | Exit Path | Biggest Risk |
|---|---|---|---|
| United States | Mega-valuations, pre-revenue, RaaS model | IPO (2027–28 window speculated) or M&A | Valuation compression if deployments stall |
| South Korea | 15x early-stage jumps, thin domestic listings | KOSDAQ or strategic acquisition | No public comps; exit window unclear |
| China | 150+ competitors, government support, shipping units | STAR Market (Unitree filed) | Commoditization, regulatory cap on foreign capital |
China’s exit picture is actually the most concrete right now. Unitree shipped more than 5,500 humanoid robots in 2025 — more than Figure AI’s entire shipment history — and filed for a $3–7 billion IPO on the Shanghai Stock Exchange. Chinese players are building at volume with lower unit costs, and that cost trajectory is the single sharpest competitive threat to the premium-priced US field. When drone and EV hardware commoditized, Chinese manufacturers won on cost. Humanoid hardware may follow the same curve.
South Korea’s Korea humanoid robotics VC exit risk is arguably the most underappreciated right now. Holiday Robotics’ $538 million Series A sets a benchmark that subsequent funders must beat at exit — and with no domestic public market for pure-play robotics and no clear acquirer pool, the math gets uncomfortable fast.
What Separates a Good Bet From a Speculative One in 2026?
Three signals separate real commercial deployment from demo-stage hype:
- Named paying customers with repeat orders. Figure’s BMW contract is real. Whether BMW scales it beyond pilot is the open question — notably, BMW already chose a different vendor for its European facility expansion.
- Disclosed unit economics. Companies with a Robot-as-a-Service model have predictable per-robot revenue structures. Startups that cannot or will not quantify their deployment economics are pricing on narrative, not fundamentals.
- Manufacturing scale-up evidence. Skild AI tripled its valuation to $14 billion in seven months; the question is not whether the AI platform works in the lab but whether the company can convert that into production contracts.
The revenue-first philosophy is the right discipline here. Industrial and logistics robots already generate revenue and can deliver measurable results. Humanoid robotics companies that cannot show a path to paid commercial deployment within 18 months of a Series A are in genuinely speculative territory, regardless of how impressive their bipedal robot demos look on YouTube.
The Honest Verdict on the Humanoid Robot Startup Valuation Bubble
This is not a binary bubble-or-no-bubble question. The sector contains at least three distinct risk categories sitting inside one funding narrative.
The first category is legitimate physical AI companies with real customers, production infrastructure, and a credible path to manufacturing scale-up. They may be expensively priced but not absurdly so given the total addressable market. The second is early-stage companies in markets like Korea, where valuations have surged 10–15x in months with no commercial deployment evidence. These are firmly in speculative zone territory. The third is the largest group: companies benefiting from proximity to the hype — suppliers, platform tools, pick-and-place specialists — that are being valued like full-stack humanoid builders because the sector label alone attracts capital.
If you are a VC analyst or retail investor trying to navigate this, the humanoid robotics bubble burst prediction depends almost entirely on which category your target company sits in. A blanket bearish call misses the companies doing real work. A blanket bullish call ignores the Tomorrow Robotics-style 15x leap with zero revenue anchoring it.
Ask for the unit economics. Ask for the named customers. Ask what the exit path looks like in a market that has produced exactly one meaningful humanoid robotics IPO filing so far. Those three questions will do more for your due diligence than any forecast multiple.
Frequently Asked Questions
Are humanoid robot startups overvalued in 2026?
Many are, particularly early-stage Korean and Chinese names with tenfold valuation jumps but no commercial revenue. US companies like Figure AI carry more deployment evidence but still have valuations that exceed Goldman Sachs’s entire 2035 market size estimate. The sector is a mixed bag, not a uniform bubble or a uniform opportunity.
Is humanoid robotics the next AI bubble?
Partly. The valuation mechanics rhyme with the dotcom era — massive pre-revenue prices, narrative-driven markups, and herd behavior from institutional capital. But leading US players have real customers and production infrastructure, which gives the sector more fundamental grounding than the dotcom peak. The bubble risk is concentrated in the earliest-stage companies, not the entire sector.
Why did Tomorrow Robotics’ valuation jump 15x in six months?
Tomorrow Robotics was valued at roughly $21.5 million in a pre-Series A late last year and is now targeting $323 million. The jump reflects a spillover effect from Holiday Robotics’ landmark Series A, which reset the entire Korean humanoid benchmark. Sector momentum, not revenue milestones, drove the repricing.
What is Figure AI’s valuation and how does it compare to revenue?
Figure AI hit a $39 billion post-money valuation in September 2025. Revenue has never been publicly disclosed. Third-party estimates suggest 2025 shipments around 150 robots, implying annual revenue likely in the low tens of millions — creating a valuation-to-revenue gap that may exceed 1,000x by some estimates.
How does the humanoid robotics funding surge compare to the dotcom bubble?
The parallels include pre-revenue pricing, rapid valuation markups, and herd capital behavior. The differences are significant too: major humanoid backers include strategic investors like Nvidia and Brookfield rather than retail speculators, and real factory deployments exist. A more precise comparison may be the 2013–2014 3D printing hype cycle than the full dotcom crash.
Which humanoid robot companies are closest to commercial deployment?
Figure AI has logged over 1,250 hours at BMW’s factory and had approximately 740 robots operating by end of June 2026. China’s Unitree shipped over 5,500 robots in 2025. Europe’s Humanoid (UK) signed a large-scale commercial agreement with Schaeffler and plans beta robot rollout in Q4 2026.
What are the biggest risks for humanoid robotics venture capital investors?
The top risks are exit bottleneck (thin public market for pure-play robotics listings), valuation compression if deployment timelines slip, hardware commoditization from Chinese volume players, real-time decision-making and dexterity limitations in uncontrolled environments, and concentration risk where a few companies take all production contracts.
Will humanoid robot startups face an IPO exit bottleneck?
Yes, for most. The speculated IPO window for top US names like Figure AI is 2027–2028 at earliest, contingent on production scaling. Korean startups face an even narrower domestic market. China’s Unitree filing is the clearest near-term IPO signal in the sector, but that is one company out of more than 150 competitors globally.
